1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: July 26 – August 1, 2026
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: July 26 – August 1, 2026

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Kyle Diamantas, J.D., Acting Commissioner of Food and Drugs

Event Date: 07/27/2026
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: David Kershenobich Stalnikowitz (Health Ministry of Mexico);

Event Date: 07/30/2026
Location: Silver Spring, MD
Subject: Roundtable on Huntington’s Disease
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Official Name: Sean R. Keveney, J.D., Chief Counsel

Event Date: 07/27/2026
Location: Washington, DC
Subject: AlloDerm Select Regenerative Tissue Matrix
FDA Participant/Group: N/A
Non FDA Participant/Group: Johanna Corbin, Karen Giardiello (AbbVie);

Event Date: 07/28/2026
Location: Silver Spring, MD
Subject: Correspondence Issues
FDA Participant/Group: DEBORAH CHASAN SLOAN; JULIE LOVAS; MATTHEW LASH; 
Non FDA Participant/Group: Colleen Heisey, John Gore (Jones Day); Carly Larson, Kelsey Mendenhall, Soleil Boughton (ForHims);

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 07/28/2026
Location: Virtual
Subject: Exploring Operation TrialBlazer: A Special Alliance Member-Only Meeting; Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Research!America reprepsentatives

Event Date: 07/29/2026
Location: Washington, DC
Subject: Biotechnology Innovation Organization (BIO) Executive Committee Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Biotechnology Innovation Organization Executive Committee members

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives

Event Date: 07/27/2026
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Susan Winckler (Reagan Udall Foundation);

Event Date: 07/31/2026
Location: Virtual
Subject: Real-Time Data Ecosystem and the Large Life Sciences Foundation Model (LSM)
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: IQVIA representatives

Official Name: Donald A. Prater, D.V.M., Acting Deputy Commissioner for Food

Event Date: 07/27/2026
Location: New Orleans, LA
Subject: The International Association for Food Protection Annual Meeting; Panelist: FSMA at 15: Promise, Progress, and Priorities for the Future
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and government

Event Date: 07/27/2026
Location: New Orleans, LA
Subject: The International Association for Food Protection Annual Meeting; Keynote: U.S. Regulatory Update on Food Safety
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and government

Official Name: Melanie Keller, M.B.A., Deputy Commissioner for Operations and Chief Operating Officer

No Significant Event

Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations

No Significant Event

Official Name: Karim Mikhail, B.Pharm, MSc, Acting Director, Center for Biologics Evaluation and Research

Event Date: 07/29/2026
Location: Silver Spring, MD
Subject: Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for Capricor
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry

Event Date: 07/30/2026
Location: Silver Spring, MD
Subject: Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for Replimune
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

Event Date: 07/27/2026
Location: Virtual
Subject: 2026 Duke-Margolis Convening on the State of Real-World Evidence Policy; Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, academia, and other stakeholders

Event Date: 07/28/2026
Location: Mountain View, CA
Subject: Roundtable on CDRH/Fogarty Innovation
FDA Participant/Group: OWEN FARIS; RICHARD ABRAMSON; 
Non FDA Participant/Group: Industry, government, academia, and other stakeholders

Official Name: Michael Davis, M.D., Ph.D., Acting Director, Center for Drug Evaluation and Research

Event Date: 07/27/2026
Location: Silver Spring, MD
Subject: Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Amy Clippinger (People for the Ethical Treatment of Animals (PETA));

Event Date: 07/27/2026
Location: Virtual
Subject: Chronic Pain Management and the Opioid Crisis
FDA Participant/Group: MARTA SOKOLOWSKA; 
Non FDA Participant/Group: Sebastian Hach (Vertanical);

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products

Event Date: 07/28/2026
Location: Silver Spring, MD
Subject: Regulation of Premium Cigars
FDA Participant/Group: MICHELE MITAL; ERIN BRANDT; WILLIAM RICH; MAY NELSON; 
Non FDA Participant/Group: Cigar Association of America representatives

Official Name: Timothy C. Schell, Ph.D., Director, Center for Veterinary Medicine

Event Date: 07/31/2026
Location: Foz do Iguaçu, Brazil
Subject: 19th International Feed Regulators Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, academia, and other stakeholders

Back to Top